• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COVID-19 - Toward a comprehensive understanding of the disease.COVID-19 - 对该疾病的全面认识。
Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7.
2
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.新冠病毒:检测、治疗与疫苗研发的基础研究
Pharm Nanotechnol. 2020;8(4):323-353. doi: 10.2174/2211738508999200817163335.
3
Statin therapy and SAR-COV-2: an available and potential therapy?他汀类药物治疗与新型冠状病毒2:一种可行且有潜力的治疗方法?
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):333-334. doi: 10.1093/ehjcvp/pvaa050.
4
Cell and animal models of SARS-CoV-2 pathogenesis and immunity.SARS-CoV-2 发病机制和免疫的细胞和动物模型。
Dis Model Mech. 2020 Sep 1;13(9):dmm046581. doi: 10.1242/dmm.046581.
5
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.一项评估静脉注射瑞维鲁单抗对比 COVID-19 重症肺炎、急性肺损伤或急性呼吸窘迫综合征患者最佳支持治疗的疗效和安全性的 III 期开放性标签、随机对照研究:一项随机对照试验研究方案的结构性总结。
Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.
6
COVID-19 challenge for modern medicine.现代医学面临的 COVID-19 挑战。
Cardiol J. 2020;27(2):175-183. doi: 10.5603/CJ.a2020.0055. Epub 2020 Apr 14.
7
Coronavirus Disease-2019 (COVID-19): An Updated Review.2019冠状病毒病(COVID-19):最新综述
Drug Res (Stuttg). 2020 Sep;70(9):389-400. doi: 10.1055/a-1217-2397. Epub 2020 Aug 3.
8
SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.SARS-CoV-2 将继续在人群中传播:从病毒与宿主关系的角度看。
Inflamm Res. 2020 Jul;69(7):635-640. doi: 10.1007/s00011-020-01352-y. Epub 2020 Apr 30.
9
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].[严重急性呼吸综合征冠状病毒2(SARS-CoV-2):我们应该针对病毒、细胞还是疾病?]
Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.
10
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和严重急性呼吸综合征冠状病毒 2(COVID-19)治疗:专利述评。
Expert Opin Ther Pat. 2020 Aug;30(8):567-579. doi: 10.1080/13543776.2020.1772231. Epub 2020 Jun 7.

引用本文的文献

1
A comparison of Gam-COVID-Vac vaccination and non-vaccination on neurological symptoms and immune response in post-COVID-19 syndrome.Gam-COVID-Vac疫苗接种与未接种疫苗对新冠后综合征患者神经症状和免疫反应的比较
Qatar Med J. 2025 Feb 23;2025(1):6. doi: 10.5339/qmj.2025.6. eCollection 2025.
2
Long-term impact of SARS-CoV-2 infection on cardiorespiratory fitness: a meta-analysis.SARS-CoV-2 感染对心肺功能的长期影响:一项荟萃分析。
Front Public Health. 2023 Oct 18;11:1215486. doi: 10.3389/fpubh.2023.1215486. eCollection 2023.
3
COVID-19 infection following influenza vaccine injection and its complications among nurses working in educational-medical hospitals of Ardabil in 2020.2020年阿尔达比勒教育医疗医院护士接种流感疫苗后感染新冠病毒及其并发症
J Family Med Prim Care. 2023 May;12(5):888-893. doi: 10.4103/jfmpc.jfmpc_1257_22. Epub 2023 May 31.
4
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome.人工智能评估托珠单抗联合皮质类固醇治疗 COVID-19 诱发的急性呼吸窘迫综合征的潜力。
PLoS One. 2023 Feb 15;18(2):e0280677. doi: 10.1371/journal.pone.0280677. eCollection 2023.
5
Effects of Multidisciplinary Rehabilitation Program in Patients with Long COVID-19: Post-COVID-19 Rehabilitation (PCR SIRIO 8) Study.多学科康复计划对新冠长期症状患者的影响:新冠后康复(PCR SIRIO 8)研究
J Clin Med. 2023 Jan 4;12(2):420. doi: 10.3390/jcm12020420.
6
COVID-19 detection using a model of photoplethysmography (PPG) signals.基于光电容积脉搏波(PPG)信号的 COVID-19 检测。
Med Eng Phys. 2022 Nov;109:103904. doi: 10.1016/j.medengphy.2022.103904. Epub 2022 Oct 8.
7
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.COVID-19 感染和 SARS-CoV-2 疫苗接种在重症肌无力中的作用。
Acta Neurol Belg. 2023 Apr;123(2):529-536. doi: 10.1007/s13760-022-02121-w. Epub 2022 Oct 24.
8
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.轻度疾病恢复期队列中急性感染期间与 SARS-CoV-2 定向体液和细胞免疫应答相关的 COVID-19 相关症状的流行率。
Int J Infect Dis. 2022 Jul;120:187-195. doi: 10.1016/j.ijid.2022.04.019. Epub 2022 Apr 14.
9
Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.宿主免疫多态性与 SARS-CoV-2 遗传变异性对 COVID-19 发展的影响。
Viruses. 2022 Jan 6;14(1):94. doi: 10.3390/v14010094.
10
Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis.COVID-19 对院内心脏骤停结局的影响:一项更新的荟萃分析。
Cardiol J. 2021;28(6):816-824. doi: 10.5603/CJ.a2021.0168.

本文引用的文献

1
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下:一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
2
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体:一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
3
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.
4
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会(ISTH)关于新冠病毒病(COVID-19)凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
5
SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.SARS-CoV-2 可在尿液、血液、肛拭子和咽拭子标本中检测到。
J Med Virol. 2020 Sep;92(9):1676-1680. doi: 10.1002/jmv.25936. Epub 2020 Apr 30.
6
Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.志愿者鼻咽拭子检测呈阳性样本中 SARS-CoV-2 在精液和尿液样本中的研究。
J Endocrinol Invest. 2020 Dec;43(12):1819-1822. doi: 10.1007/s40618-020-01261-1. Epub 2020 Apr 23.
7
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入因子与固有免疫基因一起在鼻上皮细胞中高表达。
Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23.
8
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.美国首批 12 例 2019 年冠状病毒病(COVID-19)患者的临床和病毒学特征。
Nat Med. 2020 Jun;26(6):861-868. doi: 10.1038/s41591-020-0877-5. Epub 2020 Apr 23.
9
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.中国 26 例 COVID-19 死亡患者的肾脏组织病理分析。
Kidney Int. 2020 Jul;98(1):219-227. doi: 10.1016/j.kint.2020.04.003. Epub 2020 Apr 9.
10
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.

COVID-19 - 对该疾病的全面认识。

COVID-19 - Toward a comprehensive understanding of the disease.

机构信息

Department of Cardiac Anesthesiology, Medical University of Gdańsk, Skłodowskiej-Curie 3a, 80-210 Gdańsk, Poland.

Department of Medical Immunology, Medical University of Gdansk, Dębinki 1, 80-209 Gdańsk, Poland.

出版信息

Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7.

DOI:10.5603/CJ.a2020.0065
PMID:32378729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016030/
Abstract

The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is rapidly growing. Understanding why some patients suffering from COVID-19 are getting so sick, while others are not, has become an informal imperative for researchers and clinicians around the globe. The answer to this question would allow rationalizing the fear surrounding this pandemic. Understanding of the pathophysiology of COVID-19 relies on an understanding of interplaying mechanisms, including SARS-CoV-2 virulence, human immune response, and complex inflammatory reactions with coagulation playing a major role. An interplay with bacterial co-infections, as well as the vascular system and microcirculation affected throughout the body should also be examined. More importantly, a compre-hensive understanding of pathological mechanisms of COVID-19 will increase the efficacy of therapy and decrease mortality. Herewith, presented is the current state of knowledge on COVID-19: beginning from the virus, its transmission, and mechanisms of entry into the human body, through the pathological effects on the cellular level, up to immunological reaction, systemic and organ presentation. Last but not least, currently available and possible future therapeutic and diagnostic options are briefly commented on.

摘要

新型冠状病毒 SARS-CoV-2 感染的病理生理学证据正在迅速增加。了解为什么有些 COVID-19 患者病情如此严重,而有些患者则不然,这已成为全球研究人员和临床医生的当务之急。这个问题的答案将使人们能够理性看待这场大流行带来的恐惧。对 COVID-19 病理生理学的理解依赖于对相互作用机制的理解,包括 SARS-CoV-2 的毒力、人体免疫反应以及凝血在其中发挥主要作用的复杂炎症反应。还应检查与细菌合并感染以及整个身体的血管系统和微循环的相互作用。更重要的是,全面了解 COVID-19 的病理机制将提高治疗效果并降低死亡率。在此,介绍了 COVID-19 的最新知识状况:从病毒开始,其传播途径以及进入人体的机制,通过对细胞水平的病理影响,直至免疫反应,全身和器官表现。最后但并非最不重要的是,简要评论了目前可用的和可能的未来治疗和诊断选择。